Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Akebia Therapeutics, Inc. company logo
Akebia Therapeutics, Inc. logo

Akebia Therapeutics, Inc. (AKBA)

Profile

Company profile for Akebia Therapeutics, Inc. (AKBA)
MetricValue
Full NameAkebia Therapeutics, Inc.
TickerNASDAQ: AKBA
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited States
IPO
IndexesNot included
Websiteakebia.com
Employees181

Key Metrics

Akebia Therapeutics, Inc. Key Details
MetricDateValue
Price$1.38
Price, 1D Change-1.43%
Market Cap$366M
-
PE Ratio-
Beta1.07
Revenue$160M
Revenue, 1Y Change-17.70%
EPS-$0.33
EPS, 1Y Change-18.77%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Akebia Therapeutics, Inc. chart

Events

Akebia Therapeutics, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

AKBA Estimates
MetricDateValue
EPS-$0.33
EPS Estimate$0.04
EPS Est. Change+112.16%
Revenue$160.18M
Revenue Estimate$239.31M
Revenue Est. Change+49.40%
Current Price$1.38
Price Target-$5.00
Price Tgt. Change-+262.32%

🔒 Log In To Unlock Full Data

EPS

AKBA EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.32-$0.28+13.44%
-$0.26-$0.33-26.54%
$0.04N/A+112.16%
$0.17N/A+151.67%
AKBA EPS reported versus estimate values chart

Revenue

AKBA revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$193.88M$194.62M+0.38%
$151.05M$160.18M+6.05%
$239.31MN/A+49.40%
$293.03MN/A+82.94%
AKBA revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

AKBA Performance
MetricDateValue
Price, 1Y-26.20%
Price, 3Y+98.56%
Market Cap, 1Y-12.91%
Market Cap, 3Y+186.16%
Revenue, 1Y-17.70%
Revenue, 3Y-24.32%
EPS, 1Y-18.77%
EPS, 3Y+80.64%

🔒 Log In To Unlock Full Data

Technical Indicators

AKBA Technical Indicators
MetricDateValue
Current Price$1.38
SMA 200$2.66
SMA 200 vs Price+93.09%
SMA 50$1.66
SMA 50 vs Price+20.45%
Beta1.07
ATR$0.09
14-Day RSI32.33
10-Day Volatility53.10%
1-Year Volatility84.72%

Dividends

AKBA Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

AKBA Income & Profitability
MetricDateValue
Revenue$160.18M
EPS-$0.33
Gross Profit$91.34M
Gross Margin57.03%
Operating Profit-$50.41M
Operating Margin-31.47%
Net Income-$69.41M
Net Margin-43.33%
EBITDA-$8.71M

🔒 Log In To Unlock Full Data

Financial Health

AKBA Financial Health
MetricDateValue
Debt To Equity-3.96
Current Ratio1.41
Quick Ratio1.21
-
F-Score5
Altman Z-Score-9.68

Valuations

AKBA Valuations
MetricDateValue
PE Ratio-
PS Ratio1.63
PB Ratio8.80
EV/EBITDA12.76
Enterprise ValueN/A-

Balance Sheet

AKBA Balance Sheet
MetricDateValue
Book Value-$49.19M
Cash & Equivalents$51.87M
Total Assets$220.67M
Current Assets$113.83M
Total Liabilities$269.86M
Current Liabilities$80.91M
Total Debt$194.65M
Short Term Debt$15.64M
Accounts Payable$15.18M

Expenses

AKBA Expenses
MetricDateValue
Total Expenses$229.59M
Operating Expenses$141.76M
Cost Of Goods Sold$68.84M
SG&A$0.00
D&A$41.70M
Interest Expense$0.00
Income Tax$0.00

Cash Flow

AKBA Cash Flow
MetricDateValue
CFO-$40.66M
CFI-$33.00K
CFF$49.66M
Capex$33.00K
Free Cash Flow-$40.69M

Recent analyst updates

AKBA Recent analyst updates
MetricDateValue
HC Wainwright & Co.→
BTIG→
HC Wainwright & Co.→
BTIG→
Leerink Partners
HC Wainwright & Co.→
Jefferies
Piper Sandler→
HC Wainwright & Co.→
HC Wainwright & Co.→

Analyst sentiment

Sentiment over the past month
AKBA analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
AKBA institutional ownership distribution chart

Screeners with AKBA

Data Sources & References

  1. AKBA Official Website www.akebia.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1517022/000151702225000046/0001517022-25-000046-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1517022/000162828025012470/0001628280-25-012470-index.htm
  4. AKBA Profile on Yahoo Finance finance.yahoo.com/quote/AKBA
  5. AKBA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akba

FAQ

  • What is the ticker symbol for Akebia Therapeutics, Inc.?

    The ticker symbol for Akebia Therapeutics, Inc. is NASDAQ:AKBA

  • Does Akebia Therapeutics, Inc. pay dividends?

    No, Akebia Therapeutics, Inc. does not pay dividends

  • What sector is Akebia Therapeutics, Inc. in?

    Akebia Therapeutics, Inc. is in the Healthcare sector

  • What industry is Akebia Therapeutics, Inc. in?

    Akebia Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry

  • What country is Akebia Therapeutics, Inc. based in?

    Akebia Therapeutics, Inc. is headquartered in United States

  • When did Akebia Therapeutics, Inc. go public?

    Akebia Therapeutics, Inc. initial public offering (IPO) was on March 20, 2014

  • Is Akebia Therapeutics, Inc. in the S&P 500?

    No, Akebia Therapeutics, Inc. is not included in the S&P 500 index

  • Is Akebia Therapeutics, Inc. in the NASDAQ 100?

    No, Akebia Therapeutics, Inc. is not included in the NASDAQ 100 index

  • Is Akebia Therapeutics, Inc. in the Dow Jones?

    No, Akebia Therapeutics, Inc. is not included in the Dow Jones index

  • When was Akebia Therapeutics, Inc. last earnings report?

    Akebia Therapeutics, Inc.'s most recent earnings report was on November 10, 2025

  • When does Akebia Therapeutics, Inc. report earnings?

    The next expected earnings date for Akebia Therapeutics, Inc. is March 12, 2026